Skip to main content
. 2022 May 19;12:8469. doi: 10.1038/s41598-022-12242-0

Figure 1.

Figure 1

Screening of anti-SARS-CoV-2 nucleocapsid protein clones. (a) Comparison of the recovery ratios in different rounds of phage biopanning. (b) Phage ELISA analysis of 48 clones picked from the 2nd round of panning. (c) Frequency analysis of the amino acid sequences of phage panning positive clones. (d) Determination of the binding activity of the scFv fragments to N protein by ELISA.